Casaasdas

Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor

Por um escritor misterioso
Last updated 06 julho 2024
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Cureus Tumor Necrosis Factor-Alpha (+489 G/A) Polymorphism Can
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Effects of ustekinumab on spondylitis-associated endpoints in TNFi
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Ankylosing spondylitis disease activity score is related to NSAID
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
TNF Inhibitor Therapy, Ankylosing Spondylitis
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
TNF Inhibitor Therapy, Ankylosing Spondylitis
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Frontiers Leveraging the tolerogenic potential of TNF-α and
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Disease control in patients with ankylosing spondylitis in real
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Treatment Failure in Axial Spondyloarthritis: Insights for a
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Long-Term Adherence to Etanercept in Treatment Effectiveness of
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Treat to Target in Spondyloarthritis: Myth or Reality? - European
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
The predictability of ASDAS on drug survival in patients with
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
TNF Inhibitor Therapy, Ankylosing Spondylitis
Recomendado para você
você pode gostar

© 2014-2024 importacioneskab.com. All rights reserved.